Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

HERA must address outstanding weaknesses in EU pharma framework to be successful

16 September 2021

Medicines For Europe strongly supports the EU’s drive to learn from COVID-19 […]

Read more

EU must take the lead to ensure security of supply for medicines

16 June 2021

Legislative reforms aligned with current off-patent market conditions are the […]

Read more

EU Industry Welcomes New Schengen Strategy’s Green Lanes

4 June 2021

“EU Industry Welcomes New Schengen Strategy’s Green Lanes” Read more

Read more

Opinion piece by Christoph Stoller for Friends of Europe

3 June 2021

“Too much at stake in the EU pharma strategy to […]

Read more

Open borders that prioritise essential goods key to medicines supply in Europe

2 June 2021

Open

EU Industrial strategy should be key to improving medicines supply chains

17 May 2021

The newly launched update of the industrial strategy aims to […]

Read more

“Off patent medicines essential for a fairer, healthier, and sustainable Europe” says President Christoph Stoller

30 April 2021

Christoph Stoller will speak at 3A CONFERENCE – Availability, Accessibility, […]

Read more

European patients need improved access to biosimilar medicines

22 April 2021

Fifteen years after the first global approval, biosimilar medicines systemically […]

Read more

EU Industry Welcomes New Schengen Strategy’s Green Lanes

7 April 2021

Open

New report assesses progress on biosimilar medicine policies across Europe

29 March 2021

Biosimilar medicines are increasingly relevant to public health as emphasised by the […]

Read more

Subscribe to our newsletter